Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Cycle of Blinatumomab Followed by High-dose Chemotherapy in the Induction Therapy for Ph-negative Acute Lymphoblastic Leukemia in Adults

NCT04554485 is registered in ClinicalTrials.gov with Institute of Hematology and Blood Transfusion, Czech Republic as lead sponsor.

NCT NCT04554485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04554485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Cycle of Blinatumomab Followed by High-dose Chemotherapy in the Induction Therapy for Ph-negative Acute Lymphoblastic Leukemia in Adults
Lead sponsor
Institute of Hematology and Blood Transfusion, Czech Republic
Phase
Phase 2
Overall status
Completed
Start date
May 9, 2019
Completion date
February 29, 2024
Enrollment
27 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic leukemia, acute, adult, newly diagnosed, ph negative all